Law360, New York (June 22, 2012, 8:00 PM ET) -- A Kentucky federal judge tossed the remaining allegations against generic-drug makers on Friday in the multidistrict litigation over injuries tied to Darvocet, Darvon and their generic equivalents, holding that a recent First Circuit ruling could not save claims the drugs were designed defectively.
The ruling serves as a sharp rebuke to the First Circuit's decision to uphold a $26 million award against Mutual Pharmaceutical Co. Inc. in May, one of the most significant victories for a plaintiff suing a generics maker since the U.S. Supreme Court's...
Generics Cos. Escape From Darvocet, Darvon MDL
To view the full article, take a free trial now.
